View:
United States securities and exchange commission logo
May 1, 2024
Dr. Babak A. Taheri
Chief Executive Officer
Silvaco Group, Inc.
4701 Patrick Henry Drive, Building #23
Santa Clara, CA 95054
Re: Silvaco Group, Inc.
Amendment No. 2 to
Form S-1
Filed on April 30,
2024
File No. 333-278666
Dear Dr. Babak A. Taheri:
We have reviewed your amended registration statement and have the
following
comment.
Please respond to this letter by amending your registration
statement and providing the
requested information. If you do not believe our comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell
us why in your
response.
After reviewing any amendment to your registration statement and
the information you
provide in response to this letter, we may have additional comments.
Amended Form S-1 Filed on April 30, 2024
Preliminary Results for the Three Months Ended March 31, 2024
(Unaudited), page 8
1. We note your disclosure
of a preliminary estimated range of operating income for the
quarter ended March 31,
2024. Tell us whether you have available preliminary estimates
of net income (loss)
for the quarter ended March 31, 2024. If so, please disclose or explain
to us your
consideration of why such disclosure would not be appropriate.
Dr. Babak A. Taheri
FirstName LastNameDr. Babak A. Taheri
Silvaco Group, Inc.
Comapany
May 1, 2024NameSilvaco Group, Inc.
May 1,
Page 2 2024 Page 2
FirstName LastName
Please contact Joseph Kempf at 202-551-3352 or Robert Littlepage at
202-551-3361 if
you have questions regarding comments on the financial statements and related
matters. Please
contact Matthew Crispino at 202-551-3456 or Jan Woo at 202-551-3453 with any
other
questions.
Sincerely,
Division of
Corporation Finance
Office of Technology
cc: Drew Valentine